{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:35:26Z","timestamp":1784248526063,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T00:00:00Z","timestamp":1563667200000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2314-B-002-150"],"award-info":[{"award-number":["MOST 105-2314-B-002-150"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2923-B-002-006-MY3"],"award-info":[{"award-number":["MOST 104-2923-B-002-006-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2745-B-002-004"],"award-info":[{"award-number":["MOST 104-2745-B-002-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 105-S3057"],"award-info":[{"award-number":["NTUH 105-S3057"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes, Taiwan","doi-asserted-by":"crossref","award":["NHRI-EX107-10733NI"],"award-info":[{"award-number":["NHRI-EX107-10733NI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"E-da Hospital-National Taiwan University Hospital Joint Research Program, Taiwan","award":["105-EDN11"],"award-info":[{"award-number":["105-EDN11"]}]},{"name":"Austrian Science Fund","award":["FWF I2306"],"award-info":[{"award-number":["FWF I2306"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"crossref","award":["R01 NS076517"],"award-info":[{"award-number":["R01 NS076517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"crossref","award":["R01 MH096463"],"award-info":[{"award-number":["R01 MH096463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuropharm.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T03:08:21Z","timestamp":1532142501000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The \u03b16 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation"],"prefix":"10.1016","volume":"140","author":[{"given":"Pi-Chuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Chun","family":"Hor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Tatt","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pokai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-2649","authenticated-orcid":false,"given":"Margot","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-767X","authenticated-orcid":false,"given":"Daniel E.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-940X","authenticated-orcid":false,"given":"Lih-Chu","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.07.017_bib1","doi-asserted-by":"crossref","first-page":"38934","DOI":"10.1074\/jbc.M104318200","article-title":"alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential","volume":"276","author":"Adkins","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jep.2004.09.045","article-title":"Diuretic activity of the stem-bark extracts of Steganotaenia araliacea hochst [Apiaceae]","volume":"96","author":"Agunu","year":"2005","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.wnr.0000175250.33159.a9","article-title":"Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura","volume":"16","author":"Akerman","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bjp.0706290","article-title":"Topiramate inhibits trigeminovascular activation: an intravital microscopy study","volume":"146","author":"Akerman","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0333102411418259","article-title":"Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway","volume":"31","author":"Andreou","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1476-5381.2009.00142.x","article-title":"Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation","volume":"157","author":"Andreou","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cne.20272","article-title":"Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei","volume":"478","author":"Bae","year":"2004","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/bcp.12591","article-title":"Therapeutic antibodies against CGRP or its receptor","volume":"79","author":"Bigal","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1368-5031.2005.00612.x","article-title":"Topiramate 100 mg\/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials","volume":"59","author":"Bussone","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.neuro.24.1.487","article-title":"The vanilloid receptor: a molecular gateway to the pain pathway","volume":"24","author":"Caterina","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/bph.14198","article-title":"Cerebellar alpha6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders","volume":"175","author":"Chiou","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1526-4610.1999.3910697.x","article-title":"Attenuation by butalbital of capsaicin-induced c-fos-like immunoreactivity in trigeminal nucleus caudalis","volume":"39","author":"Cutrer","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1526-4610.1996.3610579.x","article-title":"Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain","volume":"36","author":"Cutrer","year":"1996","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1476-5381.1995.tb13302.x","article-title":"Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin","volume":"114","author":"Cutrer","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.1993.tb03638.x","article-title":"Analysis of gamma-aminobutyric acidA receptor subunits in the mouse cochlea by means of the polymerase chain reaction","volume":"61","author":"Drescher","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1526-4610.2011.02053.x","article-title":"Sumatriptan inhibits TRPV1 channels in trigeminal neurons","volume":"52","author":"Evans","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0333102412455710","article-title":"Different trigemino-vascular responsiveness between adolescent and adult rats in a migraine model","volume":"32","author":"Fan","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.03.064","article-title":"Nanomolar allopregnanolone potentiates rat cerebellar GABAA receptors","volume":"383","author":"Fodor","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib23","series-title":"From Basic Pain Mechanism to Headache","first-page":"194","article-title":"Brainstem mechanisms of ongoing pain","author":"Goadsby","year":"2006"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/(SICI)1096-9861(19960212)365:3<504::AID-CNE12>3.0.CO;2-Q","article-title":"Immunocytochemical localization of the alpha 6 subunit of the gamma-aminobutyric acidA receptor in the rat nervous system","volume":"365","author":"Gutierrez","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0026-895X(25)08706-1","article-title":"Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors","volume":"49","author":"Hadingham","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib27","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1073\/pnas.0509903103","article-title":"Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4\/6beta3delta GABAA receptors","volume":"103","author":"Hanchar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneumeth.2017.04.010","article-title":"The effects of repeated nitroglycerin administrations in rats; modeling migraine-related endpoints and chronification","volume":"284","author":"Harris","year":"2017","journal-title":"J.\u00a0Neurosci. Meth."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9568.2006.04602.x","article-title":"A\u00a0local GABAergic system within rat trigeminal ganglion cells","volume":"23","author":"Hayasaki","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0028-3908(01)00158-7","article-title":"Pharmacological heterogeneity of gamma-aminobutyric acid receptors during development suggests distinct classes of rat cerebellar granule cells in situ","volume":"42","author":"Hevers","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00726-012-1456-y","article-title":"Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review","volume":"44","author":"Karim","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib32","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.7b01664","article-title":"Design and synthesis of novel deuterated ligands functionally selective for the gamma-aminobutyric acid type a receptor (GABAAR) alpha6 subtype with improved metabolic stability and enhanced bioavailability","volume":"61","author":"Knutson","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1369-1600.2010.00224.x","article-title":"Repeated moderate-dose ethanol bouts impair cognitive function in Wistar rats","volume":"17","author":"Kuzmin","year":"2012","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1526-4610.1983.hed2306258.x","article-title":"Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine","volume":"23","author":"Lance","year":"1983","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib35","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1476-5381.1995.tb16388.x","article-title":"Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation","volume":"116","author":"Lee","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the american migraine study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib37","series-title":"Handbook of Biological Statistics Sparky House Publishing","author":"McDonald","year":"2014"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molmed.2010.02.004","article-title":"TRPV1 in migraine pathophysiology","volume":"16","author":"Meents","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1471-4159.1975.tb07676.x","article-title":"Factors influencing the efflux of [3H]gamma-aminobutyric acid from satellite glial cells in rat sensory ganglia","volume":"24","author":"Minchin","year":"1975","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(98)00051-7","article-title":"The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis","volume":"76","author":"Mitsikostas","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib41","first-page":"1","article-title":"GABA potency at gaba(a) receptors found in synaptic and extrasynaptic zones","volume":"6","author":"Mortensen","year":"2011","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1876386301306010037","article-title":"The role of TRP channels in migraine","volume":"6","author":"Oxford","year":"2013","journal-title":"Open Pain J."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrn1102","article-title":"Neurobiology of migraine","volume":"4","author":"Pietrobon","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib46","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1002\/jcp.22671","article-title":"Estrogen in cycling rats alters gene expression in the temporomandibular joint, trigeminal ganglia and trigeminal subnucleus caudalis\/upper cervical cord junction","volume":"226","author":"Puri","year":"2011","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuroscience.2012.03.059","article-title":"Reduced GABA(A) receptor alpha6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity","volume":"213","author":"Puri","year":"2012","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.07.017_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-018-0676-y","article-title":"Neurogenic inflammation and its role in migraine","volume":"40","author":"Ramachandran","year":"2018","journal-title":"Semin Immunopathol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.07.017_bib70","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0065-1281(11)80146-7","article-title":"Substance P- and calcitonin gene-related peptide-like immunoreactive neurons in the rat trigeminal ganglion\u2013with special reference to meningeal and pineal innervation","volume":"92","author":"Reuss","year":"1992","journal-title":"Acta Histochem."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1073\/pnas.91.1.68","article-title":"A\u00a0method to determine the ability of drugs to diffuse through the blood-brain barrier","volume":"91","author":"Seelig","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/cne.902680403","article-title":"The central projection of masticatory afferent fibers to the trigeminal sensory nuclear complex and upper cervical spinal cord","volume":"268","author":"Shigenaga","year":"1988","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuropharm.2005.12.006","article-title":"Subunit selectivity of topiramate modulation of heteromeric GABA(A) receptors","volume":"50","author":"Simeone","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib53","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1468-2982.2004.00767.x","article-title":"Topiramate inhibits trigeminovascular neurons in the cat","volume":"24","author":"Storer","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(16)00019-3","article-title":"Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Sun","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.3022383","article-title":"A\u00a0selective imidazobenzodiazepine antagonist of ethanol in the rat","volume":"234","author":"Suzdak","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","article-title":"Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Tepper","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib57","series-title":"Prioritizing Prophylactic Treatment of Migraines","author":"Tfelt-Hansen","year":"2006"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bph.14087","article-title":"Towards functional selectivity for alpha6beta3gamma2 GABAA receptors: a series of novel pyrazoloquinolinones","volume":"175","author":"Treven","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bph.12153","article-title":"Subtype selectivity of alpha+beta- site ligands of GABAA receptors: identification of the first highly specific positive modulators at alpha6beta2\/3gamma2 receptors","volume":"169","author":"Varagic","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bph.12151","article-title":"Identification of novel positive allosteric modulators and null modulators at the GABAA receptor alpha+beta- interface","volume":"169","author":"Varagic","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0896-6273(94)90330-1","article-title":"A\u00a0novel allosteric modulatory site on the GABAA receptor beta subunit","volume":"12","author":"Wafford","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib62","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1073\/pnas.0600194103","article-title":"Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513","volume":"103","author":"Wallner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib63","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s11064-014-1243-0","article-title":"Alcohol selectivity of beta3-containing GABAA receptors: evidence for a unique extracellular alcohol\/imidazobenzodiazepine Ro15-4513 binding site at the alpha+beta- subunit interface in alphabeta3delta GABAA receptors","volume":"39","author":"Wallner","year":"2014","journal-title":"Neurochem. Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2018.07.017_bib64","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1526-4610.2005.4501006.x","article-title":"Molecular pharmacology of topiramate: managing seizures and preventing migraine","volume":"45","author":"White","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0026-895X(25)09570-7","article-title":"Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes","volume":"50","author":"Whittemore","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0091-3057(95)02076-4","article-title":"Pharmacologic actions of subtype-selective and novel GABAergic ligands in rat lines with differential sensitivity to ethanol","volume":"53","author":"Wong","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2016.07.002","article-title":"The essential role of hippocampal alpha6 subunit-containing GABAA receptors in maternal separation stress-induced adolescent depressive behaviors","volume":"313","author":"Yang","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.07.017_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuropharm.2010.07.011","article-title":"Benzodiazepine modulation of the rat GABAA receptor alpha4beta3gamma2L subtype expressed in Xenopus oocytes","volume":"59","author":"You","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.017_bib69","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/jm00010a013","article-title":"Synthesis of novel imidazobenzodiazepines as probes of the pharmacophore for \"diazepam-insensitive\" GABAA receptors","volume":"38","author":"Zhang","year":"1995","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:06:23Z","timestamp":1751756783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":70,"alternative-id":["S0028390818303782"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b16 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}